Even within a single cancer type, such as breast, prostate cancer and CRC, KLF4 can exhibit opposing activities, acting as both a suppressor and promoter, a duality dictated by its expression level and the intricate TME [7, 8, 14, 18, 51, 57]. Here, KLF4 is linked to colorectal carcinoma.